← brief for 2026-09-16 · Slowing decline

PRDM16 as a Multifaceted Pharmacological Target in Kidney Diseases: From Epigenetic Mechanisms to Therapeutic Strategies

Key takeaways

This review pulls together research on PRDM16, a protein that switches genes on and off, as a possible drug target in kidney disease. The evidence it covers comes mostly from lab and animal studies, not people yet. No drug that targets it has been tested in patients.

Who did this work

Qiuyu Dai (Shanghai Jiao Tong University) · Rong Shu (Shanghai Jiao Tong University)

Source

Paper · OpenAlex, CKD works · 2026-09-16
https://doi.org/10.3390/ph19091469